Genetic tools to target the scrub typhus bacterium
Development of genetic tools for overexpression and targeted mutagenesis of Orientia tsutsugamushi TPR proteins
This project builds genetic tools to change proteins in the scrub typhus bacterium to help researchers find better ways to diagnose and treat people at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-11240271 on NIH RePORTER |
What this research studies
If you or someone in your community is affected by scrub typhus, this project is creating new lab techniques to modify specific Orientia tsutsugamushi proteins called TPRs. The team will develop methods to overexpress those proteins and make precise mutations so scientists can see how the bacterium infects cells and evades antibiotics. The work is laboratory-based at the University of Iowa and does not offer treatment, but the results could point to targets for new diagnostics, drugs, or vaccines. Successful methods could also enable future studies that invite patient sample donation or clinical trials.
Who could benefit from this research
Good fit: People who have had scrub typhus, live in or travel to endemic areas, or can provide clinical samples would be most relevant to this research.
Not a fit: Patients with conditions unrelated to scrub typhus or those seeking immediate treatment are unlikely to benefit directly because the project focuses on laboratory tool development rather than clinical care.
Why it matters
Potential benefit: If successful, this work could speed discovery of targets for better diagnostics, treatments, and vaccines for scrub typhus.
How similar studies have performed: Genetic manipulation has helped researchers understand other bacteria, but applying overexpression and targeted mutagenesis to Orientia tsutsugamushi is largely novel and technically challenging.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Weber, Mary — University of Iowa
- Study coordinator: Weber, Mary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.